Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Net Margin (2020 - 2022)

Sonoma Pharmaceuticals (SNOA) has 3 years of Net Margin data on record, last reported at 8.72% in Q4 2012.

  • For Q4 2012, Net Margin rose 10002.0% year-over-year to 8.72%; the TTM value through Mar 2013 reached 315.88%, down 25597.0%, while the annual FY2012 figure was 58.02%, 76924.0% up from the prior year.
  • Net Margin reached 8.72% in Q4 2012 per SNOA's latest filing, up from 17.69% in the prior quarter.
  • Across five years, Net Margin topped out at 24.2% in Q1 2011 and bottomed at 1097.72% in Q2 2010.
  • Average Net Margin over 3 years is 210.84%, with a median of 34.46% recorded in 2012.
  • The widest YoY moves for Net Margin: up 92948bps in 2012, down -5867bps in 2012.
  • A 3-year view of Net Margin shows it stood at 89.32% in 2010, then dropped by -2bps to 91.29% in 2011, then surged by 110bps to 8.72% in 2012.
  • Per Business Quant database, its latest 3 readings for Net Margin were 8.72% in Q4 2012, 17.69% in Q3 2012, and 16.17% in Q2 2012.